BioMS Medical to present at BioCentury ...(atements involve risks and uncertainties...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
BioMS Medical to present at BioCentury Conference
Date:3/24/2008
atements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that MBP8298 will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
'/>"/>
| SOURCE BioMS Medical Corp. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. BioMS Medical Announces 2007 Year End Results
2. BioMS Medical to present at BIO CEO & Investor Conference
3. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
4. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
5. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
6. BioMS Medical announces third quarter 2007 results
7. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
8. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
9. BioMS Medical to present at BioContact 2007
10. BioMS Medical announces its intention to renew a normal course issuer bid
11. SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.
Post Your Comments:
Breaking Biology Technology:YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3
[0] YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES[0] Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years[0] Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner [0] Quest Diagnostics Declares Quarterly Cash Dividend
Other Biology Technology:Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S. 2Siemens Customers Innovate Their Clinical and Financial Workflows with Help from Soarian 2Siemens Customers Innovate Their Clinical and Financial Workflows with Help from Soarian 3Siemens Expands the SOMATOM Definition(TM) Line With World's First Adaptive CT Scanner 2Siemens Expands the SOMATOM Definition(TM) Line With World's First Adaptive CT Scanner 3Siemens Expands the SOMATOM Definition(TM) Line With World's First Adaptive CT Scanner 4Siemens Expands the SOMATOM Definition(TM) Line With World's First Adaptive CT Scanner 5
Breaking Biology News(10 mins):Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 3Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 4Roe of marine animals is best natural source of omega-3 2Experts: Disease-resistant plants enhance profits, client satisfaction 2SABiosciences Ranked 17th on the Best Places to Work Industry Award for Biotech and Pharmaceutical Companies 13731 1SABiosciences Ranked 17th on the Best Places to Work Industry Award for Biotech and Pharmaceutical Companies 13731 2NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 1NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 2NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 3Sinovac Wins Beijing Public Health Bureaus Bid to Supply Seasonal Flu Vaccine Anflu 28R 29 to Beijing Citizens 55599 1Sinovac Wins Beijing Public Health Bureaus Bid to Supply Seasonal Flu Vaccine Anflu 28R 29 to Beijing Citizens 55599 2Sinovac Wins Beijing Public Health Bureaus Bid to Supply Seasonal Flu Vaccine Anflu 28R 29 to Beijing Citizens 55599 3
Other Biology News:Weekends slow weight loss, researchers find 2Weekends slow weight loss, researchers find 3Gift of $100 million to transform energy and environment research at Princeton 2Gift of $100 million to transform energy and environment research at Princeton 3Gift of $100 million to transform energy and environment research at Princeton 4Political participation is partially rooted in genetic inheritance 2Political participation is partially rooted in genetic inheritance 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |